BioStock Studio: DanCann Pharma on the new agreement

Recently, biotech company DanCann Pharma signed a Letter of Intent with Canadian Tetra Bio-Pharma for the exclusive distribution rights for cannabionoid-based drugs in the Nordic region as well as in Europe’s largest pharmaceutical market – Germany. DanCann’s board member, Per Wester, visited BioStock’s studio to chisel out the significance of this agreement and talk about the visions for the future. 

Watch the video interview (in Swedish) with Per Wester at biostock.se:

https://www.biostock.se/en/biostock-studio-dancann-pharma-on-the-new-agreement/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se